Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism
Aamod S. Dekhne(Duquesne University), Larry H. Matherly(Wayne State University)
Cited by 36
Related Papers
Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
|Molecular Cancer Therapeutics|2024|13